Literature DB >> 46261

Complement-mediated release of histamine from human leukocytes.

J A Grant, E Dupree, A S Goldman, D R Schultz, A L Jackson.   

Abstract

Activation of either the alternative or classical pathway of complement generated a factor which induced release of histamine from both non-allergic and allergic human basophils. This factor probably is derived from the complement system since 1) its formation was associated with loss of C3 activity in human serum, 2) chemotactic factor, probably also a complement product, was generated simultaneously, 3) heat inactivation blocked its formation, 4) anti-C3 and anti-C5 blocked formation of the factor, and finally 5) anti-C5 inhibited the activity of the factor once it had been formed. It appears that both complement-mediated and allergen-mediated release of histamine from basophils are secretory, non-cytolytic pathways since both were maximal at 37 degrees C, required the presence of divalent cations, and were inhibited by theophylline. One consistent difference between these two mechanisms was noted: complement-initiated release of histamine occurred more quickly.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 46261

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  16 in total

1.  Ionic regulation of human basophil releasability. I. Inhibitory effect of copper.

Authors:  A Tedeschi; M Arquati; M Lorini; N Milazzo; A Miadonna
Journal:  Agents Actions       Date:  1992-09

2.  Evidence for the involvement of IgE-basophil system in acute serum sickness.

Authors:  J Benveniste; J Egido; V Gutierrez-Millet
Journal:  Clin Exp Immunol       Date:  1976-12       Impact factor: 4.330

3.  Low MW B-cell growth factor potentiates histamine release from human basophil leucocytes.

Authors:  A Tedeschi; M G Roncarolo; M Lorini; A Miadonna
Journal:  Immunology       Date:  1991-06       Impact factor: 7.397

4.  Purification and further characterization of human mononuclear cell histamine-releasing factor.

Authors:  M L Baeza; S Reddigari; M Haak-Frendscho; A P Kaplan
Journal:  J Clin Invest       Date:  1989-04       Impact factor: 14.808

5.  Inflammatory mediators released by complement-derived peptides.

Authors:  H Bult; A G Herman
Journal:  Agents Actions       Date:  1983-08

6.  Desensitization of the neutrophil aggregation response to chemotactic factors.

Authors:  J T O'Flaherty; D L Kreutzer; H S Showell; E L Becker; P A Ward
Journal:  Am J Pathol       Date:  1978-12       Impact factor: 4.307

7.  Basophil activation in idiopathic mixed cryoglobulinemia.

Authors:  A Miadonna; A Tedeschi; E Leggieri; F Invernizzi; C Zanussi
Journal:  J Clin Immunol       Date:  1982-10       Impact factor: 8.317

8.  Site-specific mutations in the N-terminal region of human C5a that affect interactions of C5a with the neutrophil C5a receptor.

Authors:  D F Carney; T E Hugli
Journal:  Protein Sci       Date:  1993-09       Impact factor: 6.725

9.  Nasal challenge with cold, dry air results in release of inflammatory mediators. Possible mast cell involvement.

Authors:  A G Togias; R M Naclerio; D Proud; J E Fish; N F Adkinson; A Kagey-Sobotka; P S Norman; L M Lichtenstein
Journal:  J Clin Invest       Date:  1985-10       Impact factor: 14.808

10.  Impaired histamine metabolism in the Arthus reaction induced in guinea-pig skin.

Authors:  S Imamura; T Tachibana; S Taniguchi
Journal:  Arch Dermatol Res       Date:  1985       Impact factor: 3.017

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.